More from one maternal blood sample.

The Non-invasive prenatal test for common recessive conditions and aneuploidies
Plus optional Red blood cell fetal Antigens

The only NIPT that includes all ACOG-recommended genetic conditions1

UNITY Screen includes screening for five common and severe recessive conditions along with aneuploidy screening. With UNITY Screen, aneuploidy NIPT and maternal carrier screening for recessive conditions are performed from one maternal blood sample. If the pregnant patient is a carrier, single-gene NIPT is automatically performed to assess fetal risk using the same sample. No partner sample needed
Optional: screening for fetal RhD status for RhD negative patients + red blood cell fetal antigens C, c, D, E, Duffy (Fya), Kell (K) for alloimmunized patients.

Recessive
Conditions

Maternal carrier screen2 is performed before single-gene NIPT

  • Cystic fibrosis
  • Spinal muscular atrophy
  • Sickle cell disease
  • Thalassemias

details

Aneuploidy

  • Trisomy 21
  • Trisomy 18
  • Trisomy 13
  • Monosomy X
  • XXY, XYY, XXX

* fetal sex optional, available for twins


details

RhD

Identifies presence of fetal D antigen

(applicable for Rh negative patients)

details

Other RBC
antigens

C, c, E, D,Duffy (Fya), and Kell (K)

(applicable for alloimmunized patients)







details

1: For general population screening, excluding population-specific recommendations (e.g., Ashkenazi Jewish populations) and individual family history. While ACOG recommends testing of such genetic conditions, not all modalities of screen specifically require sgNIPT.

2: Screening for fragile X syndrome (FXS), an X-linked condition, is also available. UNITY screens maternal blood to determine the number of CGG repeats she has in her FMR1 gene.

Did You Know

For- Providers-Image-1

58.5%

of carrier-positive mothers do not follow up with paternal testing

Know early to explore treatments.

There are emerging therapies for conditions previously considered to be untreatable that you may not know about. Identifying high-risk pregnancies early may open the door to new treatments, significantly impacting baby’s health.

spinal muscular atrophy

1 in 54 people are carriers

Therapies are most effective when initiated before symptoms begin, making prenatal diagnosis critical.

90% of SMA Type 1 infants die before age two, but effective gene therapies are available. Treatment starts days after birth.

spinal-muscular-treatment

sickle cell disease

1 in 8 African Americans are carriers

Cord blood banking at the time of birth may help treat the disease in the future.

We cover cord blood banking fees for ALL families with high-risk sickle-cell UNITY result

sickle-cell-treatment

alpha thalassemia

1 in 93 Asians are carriers

Without prenatal interventions, most babies with alpha thalassemia are stillborn.

Prenatal intervention such as transfusion and in utero stem cell transplant (currently in trial) may help babies survive.
at-treatment

UNITY screen™ in your practice

Order UNITY Screen

Add fetal antigens to order if applicable.

Collect blood sample

Collect three tubes of maternal blood.

Ship sample

Ship the sample using pre-labeled kit.

Receive results in 1 week for aneuploidy and fetal antigen NIPT; 2 weeks for carrier results and single-gene NIPT

 

Access complimentary genetic counseling

Complimentary genetic counseling sessions are available to all patients, before or after taking the test.

Affordable

All insurances including Medicaid are accepted and financial assistance is available.

Contact Us

We are here for you.

Complimentary genetic counseling is available before or after taking the test. Our board-certified genetic counselors are here to guide you through the process.

Request Kits